ClinicalTrials.gov
public full text
Public Domain
Hepatitis B Vaccine Delivered Trans-dermally by MAP
This is Phase I, randomized, open-label, active-controlled study to evaluate the safety, tolerability, and immunogenicity of a hepatitis B vaccine administered trans-dermally via microneedle array patch (MAP) compared to the intra-muscular (IM) hepatitis B vaccine (Euvax B™), administered at Day (D) 0, Week (W) 4, W26 among healthy adults aged 19 to 40 years in the Republic of Korea.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID#898476
- Immunogenicity of Hepatitis B Vaccination Among Drug Users#463760
- Infektiosität von Hepatitis-B-Virus Genotyp F- und H-pseudotypisierten Hepatitis-Delta-Viren und deren Neutralisierbarkeit durch humane und tierische Impfseren nach Hepatitis-B-Impfung#206050
- Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator#1073643
- Study on New Strategies for Hepatitis B Virus Immunization#1045748
Record · ID 886848
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive